InfuSystem Holdings, Inc.
DE ˙ DB ˙ US45685K1025
7,45 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityDE:1TZ / InfuSystem Holdings, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership72,332 shares
Latest Disclosed Value $ 667,624
Goldman Sachs Group Inc reports 23.57% decrease in ownership of 1TZ / InfuSystem Holdings, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 72,332 shares of InfuSystem Holdings, Inc. (DE:1TZ) valued at $582,273 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 94,640 shares of InfuSystem Holdings, Inc.. This represents a change in shares of -23.57% during the quarter. The current value of the position is $538,873 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INFUSYSTEM HLDGS CMN 45685K102 72,332 -22,308 -23.57 668 -21.34 0.0000
2026-02-10 2025-12-31 13F INFUSYSTEM HLDGS CMN 45685K102 94,640 -33,622 -26.21 849 -36.14 0.0001
2025-11-14 2025-09-30 13F INFUSYSTEM HLDGS CMN 45685K102 128,262 42,220 49.07 1,329 147.76 0.0002
2025-08-14 2025-06-30 13F INFUSYSTEM HLDGS CMN 45685K102 86,042 4,408 5.40 537 22.10 0.0001
2025-06-27 2025-03-31 13F/A-2 INFUSYSTEM HLDGS CMN 45685K102 81,634 -8,895 -9.83 439 -42.54 0.0001
2025-05-16 2025-03-31 13F/A-1 INFUSYSTEM HLDGS CMN 45685K102 81,634 -8,895 439 0.0001
2025-05-09 2025-03-31 13F INFUSYSTEM HLDGS CMN 45685K102 81,634 -8,895 439 0.0000
2025-02-11 2024-12-31 13F INFUSYSTEM HLDGS CMN 45685K102 90,529 9,597 11.86 765 40.96 0.0001
2024-11-14 2024-09-30 13F INFUSYSTEM HLDGS CMN 45685K102 80,932 80,932 542 0.0001
2024-05-14 2023-06-30 13F/A-1 INFUSYSTEM HLDGS CMN 45685K102 0 -24,148 -100.00 0 -100.00
2023-08-15 2023-06-30 13F INFUSYSTEM HLDGS CMN 45685K102 0 -24,148 0
2024-05-14 2023-03-31 13F/A-1 INFUSYSTEM HLDGS CMN 45685K102 24,148 823 3.53 187 -7.43 0.0000
2023-05-11 2023-03-31 13F INFUSYSTEM HLDGS CMN 45685K102 24,148 823 187 0.0000
2024-05-14 2022-12-31 13F/A-1 INFUSYSTEM HLDGS CMN 45685K102 23,325 23,325 202 0.0000
2023-02-13 2022-12-31 13F INFUSYSTEM HLDGS CMN 45685K102 23,325 23,325 202 0.0000
2024-05-14 2022-09-30 13F/A-1 INFUSYSTEM HLDGS CMN 45685K102 0 -15,519 -100.00 0 0.0000
2022-11-10 2022-09-30 13F INFUSYSTEM HLDGS CMN 45685K102 0 -15,519 0 0.0000
2024-05-14 2022-06-30 13F/A-2 INFUSYSTEM HLDGS CMN 45685K102 15,519 -52,552 -77.20 0 -100.00 0.0000
2022-08-18 2022-06-30 13F/A-1 INFUSYSTEM HLDGS CMN 45685K102 15,519 -52,552 149 0.0000
2022-08-15 2022-06-30 13F INFUSYSTEM HLDGS CMN 45685K102 15,519 -52,552 149 0.0000
2022-05-16 2022-03-31 13F INFUSYSTEM HLDGS CMN 45685K102 68,071 18,843 38.28 667 -20.41 0.0001
2022-02-17 2021-12-31 13F/A-1 INFUSYSTEM HLDGS CMN 45685K102 49,228 -114,435 -69.92 838 -60.71 0.0002
2022-02-14 2021-12-31 13F INFUSYSTEM HLDGS CMN 45685K102 49,228 -114,435 838 0.0000
2022-01-20 2021-09-30 13F/A-1 INFUSYSTEM HLDGS CMN 45685K102 163,663 11,476 7.54 2,133 -32.59 0.0005
2021-11-10 2021-09-30 13F INFUSYSTEM HLDGS CMN 45685K102 163,663 11,476 2,133 0.0001
2021-08-13 2021-06-30 13F INFUSYSTEM HLDGS CMN 45685K102 152,187 39,008 34.47 3,164 37.33 0.0007
2021-05-17 2021-03-31 13F INFUSYSTEM HLDGS CMN 45685K102 113,179 101,207 845.36 2,304 924.00 0.0006
2021-02-12 2020-12-31 13F INFUSYSTEM HLDGS CMN 45685K102 11,972 11,972 225 0.0001
2020-08-12 2020-06-30 13F INFUSYSTEM HLDGS CMN 45685K102 0 -56,290 -100.00 0 -100.00
2020-05-15 2020-03-31 13F INFUSYSTEM HLDGS CMN 45685K102 56,290 56,290 478 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.